Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma

Lignende værker

• TARGETING STAT3 ABROGATES EGFR INHIBITOR RESISTANCE IN CANCER
  af: Sen, Malabika, et al.
  Udgivet: (2012)
• Honokiol inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors
  af: Leeman-Neill, Rebecca J., et al.
  Udgivet: (2010)
• Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3
  af: Leeman-Neill, Rebecca J., et al.
  Udgivet: (2009)
• Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab
  af: Bhola, Neil E., et al.
  Udgivet: (2011)
• Targeting TORC1/2 Enhances Sensitivity to EGFR Inhibitors in Head and Neck Cancer Preclinical Models
  af: Cassell, Andre, et al.
  Udgivet: (2012)